Agree - sovereign risk excludes this from my possible buy list. The odds of a nasty backlash are just too great, given this information ... imo.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025